
Bayer, a global enterprise with core competencies in the life science fields of agriculture and healthcare, announced the launch of Felujit, an innovative fungicide designed to provide protection to all plant parts against sheath blight in paddy cultivation. The product will be available across key rice-growing states in the country starting from July.
As the agricultural sector grapples with increasing challenges from pests and diseases, Felujit, with its unique formulation combining Penflufen and Tebuconazole, is set to transform the way farmers manage this persistent disease that has origins in the soil. It effectively inhibits the growth of sheath blight by its dual mode of action throughout the entire body of the plant upon application, providing farmers with a reliable solution that enhances crop yields and quality.
A single spray of Felujit offers superior efficacy that lasts more than twice the current market standards. This means farmers can achieve effective disease control without the burden of multiple applications, saving both time and labor costs.
“Felujit is a highly effective solution for farmers, offering excellent control over sheath blight while streamlining their farming practices. Given the critical role of paddy in global food security, our innovation empowers farmers to manage disease effectively with fewer applications, optimizing their resources and enhancing their profitability amidst rising agricultural challenges”, said Mohan Babu, Cluster Commercial Lead, Crop Science Division of Bayer in India, Bangladesh & Sri Lanka.
Felujit’s unique selling proposition lies in its dual-action formulation, combining the strengths of two active ingredients to tackle Rhizoctonia, the main organism causing sheath blight. This innovative approach not only ensures effective control but also supports sustainable farming practices by optimizing the efficacy of the application. Available in convenient sizes of 320 ml and 1 litre, Felujit is poised to become an essential tool in the fight against sheath blight.